Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07108660 · ClinicalTrials.gov registry record · NA
Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction
A NA study of Central Line Associated Blood Stream Infections (CLABSI), sponsored by Swedish Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 17,800
- Enrollment target
- 19
- Study locations
NCT07108660 is a NA study of Central Line Associated Blood Stream Infections (CLABSI) that is actively recruiting participants, run by Swedish Medical Center. The registered enrollment target is 17,800 participants. The trial reports 19 study locations across 5 states.
The verdict
NCT07108660, a NA study of Central Line Associated Blood Stream Infections (CLABSI), is actively recruiting participants, sponsored by Swedish Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 17,800 participants
- Enrollment target
- 19
- Study locations
Study Summary
Prospective, multi-center, cluster-randomized trial of a hospital Infection Preventionist (IP)-led quality improvement study to provide clinical teams with just-in-time clinical education and reinforcement of existing best practices recommendations based on the output of a possible Central Line Associated Blood Stream Infection (CLABSI) Machine Learning (ML) prediction model. The objective is to determine whether providing this model to Infection Preventionists will decrease the CLABSI rates versus routine clinical practice.
Conditions Studied
Interventions
- BEHAVIORAL Infection Preventionist Led Best Practices Reminders
Study Locations (19)
California
- St. Mary Medical Center - Apple Valley
- Providence Saint Joseph Medical Center - Burbank
- St. Jude Medical Center - Fullerton
- Providence Holy Cross Medical Center - Mission Hills
- Mission Hospital - Mission Viejo
- Queen of the Valley Medical Center - Napa
- St. Joseph Hospital - Orange
- Santa Rosa Memorial Hospital - Santa Rosa
- Providence Cedars-Sinai Tarzana Medical Center - Tarzana
Washington
- Swedish Medical Center Edmonds - Edmonds
- Providence Regional Medical Center Everett - Everett
- Providence St. Peter Hospital - Olympia
- Kadlec Regional Medical Center - Richland
- Swedish Medical Center Cherry Hill - Seattle
- Swedish Medical Center First Hill - Seattle
- Providence Sacred Heart Medical Center - Spokane
Alaska
- Providence Alaska Medical Center - Anchorage
Oregon
- Providence St. Vincent Medical Center - Portland
Texas
- Covenant Medical Center - Lubbock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17,800 participants |
| Start Date | 2025-07-01 |
| Est. Completion | 2027-12 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07108660
The ClinicalTrials.gov registry entry for NCT07108660 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 17,800 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Swedish Medical Center, which has 30 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Central Line Associated Blood Stream Infections (CLABSI) appearing as the primary indexed condition, and to 1 intervention - of which Infection Preventionist Led Best Practices Reminders is the first listed.
NCT07108660 reports 19 study locations spanning 5 distinct geographic areas - top geographies include California, Washington, Alaska.
Frequently Asked Questions
What is clinical trial NCT07108660 about?
NCT07108660 is a clinical study titled "Machine Learning Prediction of Possible Central Line Associated Blood Stream Infections and Rate of Reduction". Prospective, multi-center, cluster-randomized trial of a hospital Infection Preventionist (IP)-led quality improvement study to provide clinical teams with just-in-time clinical education and reinforcement of existing best practices recommendations based on the output of a possible Central Line Asso...
What is the current status of trial NCT07108660?
This trial is currently recruiting. It is a NA study. The enrollment target is 17,800 participants. The study started on 2025-07-01. Estimated completion is 2027-12.
What conditions does trial NCT07108660 study?
This clinical trial studies the following conditions: Central Line Associated Blood Stream Infections (CLABSI).
What interventions are being tested in trial NCT07108660?
The interventions under investigation include: Infection Preventionist Led Best Practices Reminders (BEHAVIORAL).
Who is sponsoring clinical trial NCT07108660?
This trial is sponsored by Swedish Medical Center, which has 30 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07108660 being conducted?
This trial has 19 study locations across Alaska, California, Oregon, Texas, Washington. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Central Line Associated Blood Stream Infections (CLABSI)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.